Advanced search

Filters

Country

All countries

North America

South America

Europe

Africa

Middle East

Asia

Oceania

Central America

Select all

Capitalization

Sector

All sectors

  Energy

  Basic Materials

  Industrials

  Consumer Cyclicals

  Consumer Non-Cyclicals

  Financials

  Healthcare

  Technology

  Utilities

  Real Estate

  Institutions, Associations & Organizations

  Government Activity

  Academic & Educational Services

Select all

Add a keyword

Announcement Date

Since

Until

262 Results

Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Evotec, Inserm, Lille University Hospital and Inserm Transfert enter collaboration to identify novel therapeutic targets in obesity and metabolic diseases
EQ
Transcript : Evotec SE, Q1 2024 Earnings Call, May 22, 2024
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
GL
DD: Evotec SE: Dr. Cord Dohrmann, Restricted shares granted as Short Term Variable Incentive (Bonus) for 2023 pursuant Evotec’s remuneration system.
EQ
Evotec : Remuneration report 2023 on agenda item 5,
PU
Evotec : Convening and Agenda of the Annual General Meeting,
PU
Evotec : Information pursuant to § 125 para. 1 AktG in conjunction with. §125 para. 5 AktG, Article 4 para. 1 as well as Table 3 of the Annex to the Implementing Regulation (EU) 2018/1212,
PU
Bayer and Evotec collaborate to advance precision cardiology
EQ
Transcript : Evotec SE, 2023 Earnings Call, Apr 24, 2024
Evotec : Corporate governance declaration for the 2023 financial year,
PU
Evotec : Declaration on Corporate Governance 2023 581.471 KB
PU
DD: Evotec SE: Dr. Cord Dohrmann, sell
EQ
Transcript : Evotec SE - Special Call
DD: Evotec SE: Dr. Cord Dohrmann, Purchase of shares by exercising stock options (Share Performance Plan)
EQ
DD: Evotec SE: Dr. Cord Dohrmann, Purchase of shares by exercising stock options (Share Performance Plan)
EQ
DD: Evotec SE: Dr. Cord Dohrmann, Purchase of shares by exercising stock options (Share Performance Plan)
EQ
DD: Evotec SE: Dr. Cord Dohrmann, Exercise against Cash Settlement (Share Performance Plan)
EQ
DD: Evotec SE: Dr. Cord Dohrmann, Exercise against Cash Settlement (Share Performance Plan)
EQ
DD: Evotec SE: Dr. Cord Dohrmann, Exercise against Cash Settlement (Share Performance Plan)
EQ
Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb
EQ
Evotec receives US$ 2.5 m grant to leverage human iPSC-derived teratogenicity platform for global health programmes
EQ
Evotec enters partnership with Charité to expand molecular patient database in autoimmune diseases
EQ
Evotec SE, Video recording of Capital Markets Day presentations published
AQ
Transcript : Evotec SE - Analyst/Investor Day
Evotec presents precision medicine platforms for accelerated pipeline building at Capital Markets Day
EQ
Transcript : Evotec SE, Nine Months 2023 Earnings Call, Nov 08, 2023
Transcript : Evotec SE, H1 2023 Earnings Call, Aug 29, 2023
Evotec and Bristol Myers Squibb enter licence agreement within neuroscience partnership
EQ
Evotec receives milestone payment for first patient dosed in Phase I study of Bayer kidney disease programme
EQ
Evotec-Sernova Partnership, Successful Results Presented at the 4th IPITA/HSCI/JDRF Summit
AQ
Successful Results Using Sernova's Cell Pouch System with Evotec's iPSC-Derived Islet-like Clusters for Type 1 Diabetes Presented at the 4th IPITA / HSCI / JDRF Summit
AQ
Successful Results Using Sernova’s Cell Pouch System™ with Evotec’s iPSC-Derived Islet-like Clusters for Type 1 Diabetes Presented at the 4th IPITA / HSCI / JDRF Summit
AQ
Evotec and Bristol Myers Squibb extend and expand strategic neurodegeneration partnership
EQ
Evotec announces progress in strategic protein degradation partnership with Bristol Myers Squibb
EQ
Evotec : partner Sernova to present at the 4th IPITA / HSCI / JDRF Summit
PU
Sernova Announces Upcoming Podium Presentation of iPSC and Cell Pouch™ Combination Treatment for Type One Diabetes at the 4th IPITA / HSCI / JDRF Summit
EQ
Sernova Announces Upcoming Podium Presentation of iPSC and Cell Pouch™ Combination Treatment for Type One Diabetes at the 4th IPITA / HSCI / JDRF Summit
AQ
Evotec : announces agreement with Janssen to develop immune-based therapies
PU
Evotec announces agreement with Janssen to develop immune-based therapies
EQ
DD: Evotec SE: Dr. Cord Dohrmann, Purchase of shares by exercising stock options (Share Performance Plan)
EQ
DD: Evotec SE: Dr. Cord Dohrmann, Exercise against cash settlement (Share Performance Plan)
EQ
Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes
EQ
Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes
AQ
Evotec achieves further progress in neuroscience collaboration with Bristol Myers Squibb
AQ
Evotec achieves further progress in neuroscience collaboration with Bristol Myers Squibb
EQ
Transcript : Evotec SE, Nine Months 2022 Earnings Call, Nov 09, 2022
Evotec enters partnership with Hannover Medical School to create molecular patient database in autoimmune diseases
AQ
Evotec enters partnership with Hannover Medical School to create molecular patient database in autoimmune diseases
EQ
Evotec launches PanOmics data analysis platform PanHunter at Bio-IT World
EQ
Central Glass : Notice regarding the disposal of shares in consolidated subsidiary (transfer of shares)（318KB）
PU
No results for this search
  1. Stock Market
  2. Advanced search
  3. Cord Dohrmann
  4. News